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Agrobacterium VirB2 pilin is required for assembly of the VirB/VirD4 type IV secretion system (T4SS). The
propilin is processed by signal sequence cleavage and covalent linkage of the N and C termini, and the cyclized pilin
integrates into the inner membrane (IM) as a pool for assembly of the secretion channel and T pilus. Here, by use
of the substituted cysteine accessibility method (SCAM), we defined the VirB2 IM topology and then identified
distinct contributions of the T4SS ATPase subunits to the pilin structural organization. Labeling patterns of
Cys-substituted pilins exposed to the membrane-impermeative, thiol-reactive reagent 3-(N-maleimidopropio-
nyl)biocytin (MPB) supported a topology model in which two hydrophobic stretches comprise transmembrane
domains, an intervening hydrophilic loop (residues 90 to 94) is cytoplasmic, and the hydrophilic N and C
termini joined at residues 48 and 121 form a periplasmic loop. Interestingly, the VirB4 ATPase, but not a
Walker A nucleoside triphosphate (NTP) binding motif mutant, induced (i) MPB labeling of Cys94, a residue
that in the absence of the ATPase is located in the cytoplasmic loop, and (ii) release of pilin from the IM upon
osmotic shock. These findings, coupled with evidence for VirB2-VirB4 complex formation by coimmunoprecipita-
tion, support a model in which VirB4 functions as a dislocation motor to extract pilins from the IM during T4SS
biogenesis. The VirB11 ATPase functioned together with VirB4 to induce a structural change in the pilin that was
detectable by MPB labeling, suggestive of a role for VirB11 as a modulator of VirB4 dislocase activity.
The Agrobacterium tumefaciens VirB/VirD4 type IV secre-
tion system (T4SS) delivers effector proteins and DNA to plant
cells during infection (1, 14). The 11 VirB proteins and VirD4
substrate receptor mediate assembly of the envelope-spanning
translocation channel, whereas the VirB proteins indepen-
dently of VirD4 are required for polymerization of the extra-
cellular T pilus (6, 32, 46). These T4SS subunits include the
three ATPases VirD4, VirB4, and VirB11; a trans-envelope
core complex comprised of VirB7, VirB9, and VirB10; sub-
units involved in assembly or spatial positioning of the core
complex (VirB1, VirB6, and VirB8); and other structural com-
ponents (VirB2 pilin, VirB3, and pilus-associated VirB5) (1,
14, 43, 48, 55, 70). The VirB/VirD4 subunits are conserved
among many Gram-negative bacterial T4SSs, and recent struc-
tures of homologs of VirD4, VirB5, VirB8, VirB10, and
VirB11 and a VirB7/VirB9/VirB10 machine subassembly are
supplying exciting new information about T4SS machine archi-
tectures (11, 28, 29).
The pilin subunit VirB2 is a component of both the secretion
channel and T pilus (39, 47, 48). Its role in substrate transfer
was established with a modified chromatin immunoprecipita-
tion (ChIP) assay termed transfer DNA (T-DNA) immuno-
precipitation (TrIP), wherein the pilin (but not the T pilus) was
shown to form formaldehyde-cross-linkable contacts with the
translocating T-DNA substrate (10). TrIP studies with virB
mutant strains also supplied evidence that VirB2 occupies a
distal portion of the translocation channel near or at the outer
membrane (OM) (10). Complementary genetic studies identi-
fied mutations in several VirB subunits, including VirB6,
VirB9, VirB10, and VirB11, that selectively block T pilus pro-
duction without affecting substrate transfer (39, 40, 41, 62).
These Tra Pil “uncoupling” mutations do not bypass the
requirement for VirB2 production for substrate transfer, as the
further deletion of virB2 from the Tra Pil mutant strains
renders these strains transfer defective (39, 41, 62). Therefore,
VirB2 pilin, but not an intact T pilus, is required for passage of
substrates to target cells.
The pathways culminating in the integration of VirB2 into
the two terminal organelles, the secretion channel and T pilus,
are fundamentally poorly understood. The early VirB protein-
independent reactions involve insertion of the 12.3-kDa pro-
pilin into the inner membrane (IM); cleavage of a long, 47-
residue signal sequence, presumably by LepB signal peptidase;
and covalent joining of the N-terminal Gln48 and C-terminal
Ser121 to form the mature, cyclic pilin (24). This unusual
head-to-tail cyclization reaction was also shown for the VirB2
homolog, TrbC (24/51% sequence identity/similarity) of plas-
mid RP4 (24, 34, 44). Other VirB2 homologs, such as F plas-
mid TraA (19/47% identity/similarity) (67), remain linear al-
though their N termini are modified by N acetylation (54).
Prevailing models suggest that mature forms of conjugative
pilins accumulate in the IM as pools for use in assembly of the
channel/pilus upon receipt of an unknown morphogenetic sig-
nal(s). The IM-integrated VirB2, TraAF, and TrbCRP4 pilins
likely adopt similar topologies, as deduced from similar pre-
dicted secondary structures and results of reporter fusion stud-
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ies with periplasmically active alkaline phosphatase (PhoA) (5,
22, 56). Two hydrophobic domains are thought to orient across
the IM so that a small, intervening hydrophilic loop is cyto-
plasmic and the hydrophilic N and C termini are periplasmic.
Detailed studies confirming this overall topology are lacking,
and limited information exists regarding the nature of pilin
interactions with other T4SS subunits (36, 51). Furthermore,
little is known about the mechanism or energetic requirements
for dislocation of membrane-integrated forms of conjugative
pilins during machine morphogenesis.
In A. tumefaciens, mutations in the Walker A nucleoside
triphosphate (NTP) binding site motifs of the VirB4 and
VirB11 ATPases render cells defective for substrate transfer
and pilus production, indicating that NTP energy consumption
by both ATPases is essential for assembly of the two terminal
organelles (6, 7, 58, 62, 68). VirB4-like subunits are signatures
of all T4SSs described to date, whereas VirB11-like proteins
are common but not ubiquitous among the T4SSs (1). Some
T4SSs, such as the conjugation machines encoded by Esche-
richia coli F-like plasmids, lack VirB11 homologs, and yet their
conjugative pili extend and retract dynamically by a mecha-
nism(s) dependent on VirB4 homologs (18, 65). On the basis
of these observations, it is reasonable to propose that the
VirB4-like subunits catalyze early reactions associated with
assembly of conjugative pili.
Here, we used the scanning cysteine accessibility method
(SCAM) (9) to define the IM topology of cyclized VirB2. We
then assayed for contributions of VirB subunits to the pilin
structural organization. We present biochemical evidence for
VirB4-mediated dislocation of VirB2 pilin from the membrane
and also for a contribution by VirB11 in modulating pilin
tertiary or quaternary structure. We discuss our findings in the
context of recent advances in our understanding of T4SS ma-
chine assembly and architecture.
MATERIALS AND METHODS
Bacterial strains and induction conditions. A348 carries the octopine-type
plasmid pTiA6NC (wild type [WT]) (33). PC1000 (virB operon), PC1004
(virB4), and PC1211 (virB2 virB11) are A348 derivatives (6, 26, 39). Strains
JK1002, carrying a nonpolar deletion of virB2 (virB2), and JK1204, deleted of
virB2 and virB4 (virB2 virB4), were constructed as follows. The sacB suicide
plasmid pJEK03, which carries a nonpolar deletion of virB2 (see below), was
introduced by transformation into wild-type A348 and the virB4 mutant,
PC1004. The virB2 mutation was inserted into the virB2 locus by marker
exchange eviction, as described previously (6). Both the deletion mutations and
nonpolarity of the deletions in the resulting strains, JK1002 (virB2) and JK1204
(virB2 virB4), were confirmed by immunodetection of VirB proteins synthe-
sized from downstream genes and trans complementation assays, as described
previously (6). Conditions for growth of A. tumefaciens and Escherichia coli and
for vir gene induction with 100 M acetosyringone (AS) in induction medium
(ABIM) have been described previously (6). Plasmids were maintained in A.
tumefaciens and E. coli by addition of carbenicillin (100 g/ml), kanamycin (50 to
100 g/ml), tetracycline (5 g/ml), and gentamicin sulfate (20 to 100 g/ml).
Protein analysis and immunoblotting. Proteins were resolved by sodium do-
decyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) or a Tricine–SDS-
PAGE system as previously described (59). Proteins were transferred to nitro-
cellulose membranes, and immunoblots were developed with goat anti-rabbit
antibodies conjugated to alkaline phosphatase and histochemical substrates.
Alternatively, blots were developed with anti-rabbit antibodies conjugated to
horseradish peroxidase, and antibody-antigen interactions were visualized by
chemiluminescence (Pierce, Thermo Scientific). Prestained SDS-PAGE molec-
ular size markers were from Bio-Rad.
Plasmid constructions. The plasmids used in this study are listed in Table 1.
Plasmid pJEK01, expressing PvirB-virB2C64S, was constructed as follows. Plasmid
pPC927, which carries an NdeI restriction site at the start of virB2 (6), was used
as the template to construct the virB2 C64S codon substitution with the muta-
genic oligonucleotide listed in Table 1. A 0.5-kb NdeI-XmnI fragment carrying
only virB2C64S was introduced downstream of the PvirB promoter, substituting
for virB1 of pPC914. Plasmid pJEK1 served as the template for construction of
the Cys substitution mutations by Kunkel or QuikChange (Stratagene) mutagen-
esis as described previously (6). The mutagenic oligonucleotides listed in Table
1 carried the Cys substitution codon and at least 15 bp of 5 and 3 flanking
complementary sequences. Cys substitution mutations were identified by restric-
tion enzyme digestion and confirmed by sequencing. The resulting plasmids were
designated pJKxx, where xx denotes the number of the substituted residue
(relative to the N-terminal Met of the propilin). The pJKxx plasmids were
introduced into A. tumefaciens strains by ligation to the IncP plasmid pXZ151
(Kanr) or pBBR1MCS (Genr or Kanr), resulting in plasmid pJKBxx or pJKBBxx,
respectively. Plasmid pJEK02 was constructed by deleting a 46-bp EcoRV inter-
nal fragment in virB2 from plasmid pBB8 (6). Plasmid pJEK03, used to generate
nonpolar virB2 deletions on the Ti plasmid, was constructed by introducing a
2.9-kb BamHI-SalI fragment from pJEK02 that encompasses the virB2 muta-
tion and 5 and 3 flanking sequences into the corresponding sites of the sacB-
containing plasmid pBB50 (6). Plasmid pKA93 expresses PvirB-virB4 from the
broad-host-range vector pBBR1MCS2Gr (3). Plasmid pKA96, expressing PvirB-
virB4K439Q, is pBBR1MCS2Gr with a 2.4-kb XbaI/XhoI fragment from pBB11
(6). Plasmid pKA94, expressing PvirB-virB4 and PvirB-virB11, is a cointegrate of
plasmids pKA93 and pSR1 joined at their respective XhoI sites (58).
T pilus isolation and fractionation. A. tumefaciens strains were grown to an
optical density at 600 nm (OD600) of 0.5 in MG/L medium at 28°C and then
induced with acetosyringone (AS) for expression of the vir genes for 6 h at 22°C,
as described previously (26). The induced culture (500 l) was spread on ABIM
agar plates, and the plates were incubated for 4 days at 18°C. Cells were then
gently scraped off the plates in 1 ml 50 mM KPO4 buffer (pH 5.5) or buffer A
(100 mM HEPES [pH 7.5], 250 mM sucrose, 25 mM MgCl2, 0.1 mM KCl) and
passed through a 25-gauge needle to collect flagella, pili, and surface proteins.
The sheared material was centrifuged at 14,000  g for 30 min at 4°C, and the
supernatant was filtered through a 0.22-m-pore-size cellulose acetate mem-
brane to remove intact cells and cell debris. The filtered fraction was centrifuged
at 100,000  g for 1 h at 4°C to recover T pili or, alternatively, prepared for
viewing in the electron microscope (see below). T pili were either suspended in
50 l of Laemmli buffer and boiled or suspended in 500 l KPO4 buffer (pH 5.5)
and further fractionated through a 20 to 70% sucrose density gradient as de-
scribed previously (61). Enriched T pili were used in Cys labeling studies, as
described below.
Extracellular VirB2 blot assay. Surface-exposed VirB2 was detected by colony
immunoblotting as described previously (40).
Conjugation assays. The IncQ plasmid pML122 (Genr) was introduced into
various A. tumefaciens donor strains by diparental mating with E. coli strain
S17-1(pML122) (42, 62). A. tumefaciens strains carrying pML122 were mated
with A348Spcr recipient cells, as described previously (62). Transfer frequencies
are reported as transconjugants recovered per donor cell. Experiments were
repeated in triplicate, and results of a representative experiment are reported.
Virulence assays. A. tumefaciens strains were tested for virulence by inoculat-
ing wound sites of Kalanchoe daigremontiana leaves. As controls, all leaves were
coinoculated with WT A348 and isogenic null mutants as positive and negative
controls (6). Relative virulence was assessed by inoculation of serially diluted
cultures adjusted to the same OD600 on plant wound sites. Tumor formation was
monitored over a period of 6 weeks and scored on a scale of  (avirulent)
to  (WT virulence).
Chemical labeling of cysteine residues. Cysteine accessibility experiments were
carried out as described previously (41) with minor modifications. Briefly, A.
tumefaciens strains producing VirB2 Cys derivatives were induced for vir gene
expression by growth at 22°C in ABIM to an A600 of 0.5. Cells from 25-ml
cultures were harvested, resuspended in buffer A (100 mM HEPES [pH 7.5 or
pH 9.5], 250 mM sucrose, 25 mM MgCl2, 0.1 mM KCl), and distributed into two
centrifuge tubes to a final A600 of 12 in 500 l of buffer A. To one cell suspen-
sion, 4-acetamido-40-maleimidylstilbene-2,20-disulfonic acid (AMS) (Molecular
Probes) was added to a final concentration of 5 mM, and cells were incubated for
30 min at 25°C. AMS was removed by suspending cells in 10 ml of buffer A and
centrifuging. The washed cell pellet was suspended in 500 l of buffer A. To the
AMS-pretreated cells and the second cell suspension, 3-(N-maleimidylpropio-
nyl)biocytin (MPB) (Molecular Probes) was added to a final concentration of 100
M (from a 20 mM stock freshly dissolved in dimethyl sulfoxide [DMSO]), and
the cells were incubated for 5 min at 25°C. The final concentration of DMSO in
the reaction mixture did not exceed 0.5% (vol/vol). -Mercaptoethanol (-ME)
(20 mM final concentration) was added to quench biotinylation, and cells were
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washed twice in buffer A containing 20 mM -ME. As controls, sonicated ex-
tracts were treated with MPB to monitor Cys accessibility of presumptive cyto-
plasmic residues. For labeling of T pili, the isolated T pili in 500 l of buffer A
were treated with 100 M MPB (final concentration) and incubated for 5 min at
25°C. -ME (40 mM final concentration) was added to quench biotinylation, T
pili were pelleted by high-speed centrifugation (100,000  g), and MPB labeling
of Cys-substituted pilin was assessed as described below.
Detection of labeled Cys residues. MPB-treated cells or T pili were suspended
in 200 l TE (10 mM Tris [pH 7.5], 5 mM EDTA) with 2% (wt/vol) SDS and then
vortex mixed vigorously for 30 min at 37°C. Samples were then diluted with 250
TABLE 1. Strains, plasmids, and oligonucleotide primers for virB2 mutagenesis
Bacterial strain, plasmid,
or mutation Relevant characteristics or 5 primer sequence
a Reference or
source
Strains
E. coli
DH5 	
80d/lacZM15 (lacZYA-argF)U169 recA1 endA1 hsdR17(rK
 mK
)
supE44 thi-1 gyrA relA1
GIBCO-BRL
S17-1 Tra genes from pRP4 integrated into chromosome Bio-Rad
A. tumefaciens
A348 A136 containing pTiA6NC 33
A348Spcr A348 with Spcr by spontaneous mutagenesis 62
PC1000 A348 deleted of entire virB operon from pTiA6NC 27
PC1002 A348 deleted of virB2 from pTIA6NC; polar on virB3 6
PC1004 A348 deleted of virB4 from pTIA6NC 7
PC1011 A348 deleted of virB11 from pTIA6NC 6
PC1211 A348 deleted of virB2 and virB11 from pTIA6NC 39
JK1002 A348 deleted of virB2 from pTiA6NC This study
JK1204 A348 deleted of virB2 and virB4 from pTiA6NC This study
Plasmids
Plasmid vectors
pBSIIKS.NdeI Crbr; cloning vector containing NdeI restriction site at the translational start site of lacZ 6
pXZ151 Kanr; broad-host-range IncP plasmid containing Plac with downstream polylinker sequence 75
pBBR1MCS2Kr Kanr; broad-host-range cloning vector 45
pBBR1MCS2Gr Genr; broad-host-range cloning vector 21
pML122Kr Genr; IncQ RSF1010 derivative 31
pBB50 Kanr; 3-kb BamHI fragment containing nptII and the Bacillus subtilis sacB gene in pUC7 6
virB expression plasmids
pJEK01 Crbr; pBIIKS.NdeI expressing PvirB-virB2C64S This study
pJEK02 Crbr; pBB8 with a virB2 internal deletion This study
pJEK03 Crbr Kanr; sacB-containing pBB50 (8) with the virB2 mutation and flanking sequences
from pJK002
This study
pPC914 Crbr; pBIIKS.NdeI expressing PvirB-virB1 6
pPC927 Crbr; pBIIKS expressing PvirB-virB1, virB2 with NdeI at start site, and virB3 6
pKA93 Genr; pBBR1MCS2Gr expressing PvirB-virB4 3
pKA96 Genr; pBBR1MCS2Gr expressing PvirB-virB4K439Q This study
pKA94 Genr; pBBR1MCS2Gr expressing PvirB-virB4 and PvirB-virB11 This study
pJKxx pJEK01 with VirB2 Cys substitutions; xx denotes the position of the codon replacement This study
pJKBxx Crbr Kanr; pXZ151 ligated to pJKxx plasmids This study
pJKBBxx Crbr Genr; pBBR1MCS2Gr ligated to pJKxx plasmids This study
pXZB100 Crbr Kanr; pXZ151 with PvirB-virB11 76
pPCB39 Crbr Kanr; pXZ151 with PvirB-virB11K175Q 58
Mutation
C64S 5-GGT TAA CAA TAT AAG TAC GTT TAT CC-3
G51C 5-CAA TCT GCG TGC GGC GGT ACC GAC CCC-3
T54C 5-CAA TCT GCA GGT GGC GGC TGC GAC CC-3
T58C 5-GCA CCG ACC CCG CAT GCA TGG TTC AC-3
I67C 5-GCA CGT TTT GCC TTG GTC CGT TC-3
F71C 5-CTT GGT CCG TGC GGC CAG TCA CTC-3
V77C 5-CAG TCA CTC GCA TGC CTC GGC ATT GT-3
I83C 5-GGC ATT GTC GCA TGC GGG ATC TCC TG-3
I85C 5-CGC TAT CGG GTG CTC CTG GAT GTT C-3
S86C 5-GCT ATC GGG ATC TGC TGG ATG TTC GGG-3
M88C 5-GAT CTC CTG GTG CTT CGG GCG GGC TTC-3
L94C 5-CGG GCT TCG TGC GGG CTG GTT G-3
I104C 5-GTC GGC GGC TGC GTT ATC ATG TTT GG-3
M107C 5-GGC ATT GTT ATC TGC TTT GGG GCG AGC-3
S111C 5-CAT GTT TGG GGC ATG CCT CGG C-3
L117C 5-CCT CGG CCA AAC GTG CAC TGG CGG-3
G119C 5-GGC CAA ACG TTA ACT TGC GGT AG-3
a SphI restriction sites (GCATGC) are in bold; Cys (TGC) or Ser (AGT) codons are underlined. Antisense oligonucleotides were the reverse complement of the
sense primers shown.
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l of buffer B (150 mM Tris [pH 8.0], 0.5 M sucrose, 10 mM EDTA). Lysozyme
(1-mg/ml final concentration) was added, and the samples were incubated on ice
for 1 h and then vortex mixed for 15 min at 37°C. Triton X-100 (20 l),
EDTA-free protease inhibitor cocktail (30 l; Pierce Biochemicals) and 13 l of
1 M MgCl2 stock solution were added, and the samples were vortexed for 10 min
at 25°C and then incubated with gentle rocking for 3 h at 4°C. Samples were
diluted with 900 l of buffer B, and cell debris was removed by centrifugation at
14,000  g for 15 min. Protein A–Sepharose CL-4B (Pharmacia) (30-l bed
volume) was incubated with the supernatant for 60 min at 25°C and centrifuged
at 5,000  g to remove protein A-Sepharose and nonspecifically bound proteins.
Anti-VirB2 antibodies coupled to protein A-Sepharose were added to the su-
pernatant and incubated overnight at 4°C. The beads were washed twice in buffer
B with 1% Triton X-100 for 10 min, once in buffer B with 0.1% Triton X-100 for
10 min, and once in buffer B for 5 min and then resuspended in 15 l of 5
Laemmli buffer plus 15 l buffer B. Samples were boiled for 5 min and centri-
fuged at 400  g for 5 min, and the solubilized proteins were subjected to Tricine
SDS-PAGE and transferred to nitrocellulose membranes (0.45-m pore size).
Membranes were incubated overnight in blocking buffer (1 phosphate-buffered
saline [PBS], 0.1% Tween 20, 5% [wt/vol] bovine serum albumin [BSA]) and then
for 4 h in the presence of avidin-horseradish peroxidase (HRP) (Pierce) (2:
10,000 dilution of a 2-mg/ml stock solution). Blots were washed three times in
buffer C (1 PBS, 0.1% Tween 20, 0.5% BSA), and biotinylated proteins were
analyzed by chemiluminescence according to the manufacturer’s (Pierce,
Thermo Scientific) instructions.
Coimmunoprecipitation. Coimmunoprecipitation was performed as described
previously (42). Briefly, 500 ml of induced A. tumefaciens cultures were har-
vested, and cells were lysed by French press treatment. Total membranes were
recovered by ultracentrifugation, cross-linked with 0.5 mg/ml of dithiobissucci-
dimidyl propionate (DSP), and solubilized with radioimmunoprecipitation assay
(RIPA) buffer (50 mM Tris [pH 7.6], 150 mM NaCl, 1% NP-40, 0.5% sodium
deoxycholate, 0.1% SDS). The solubilized membranes were used as starting
material for immunoprecipitation with anti-VirB4, anti-VirB11, or anti-VirB2
antibodies coupled to protein A–Sepharose CL-4B beads (Amersham Bio-
sciences).
Osmotic shock. Cells were osmotically shocked as described by Chen et al.
(13). Briefly, A. tumefaciens strains were induced for vir gene expression by
growth in ABIM to an A600 of 0.5. Cells from 65-ml cultures were harvested (final
A600 of 18), resuspended in 8 ml (4°C) osmotic shock buffer (20% [wt/vol]
sucrose, 33 mM Tris-HCl [pH 8.0], 5 mM CaCl2, and 0.5 mM Na2 EDTA). After
a shaking incubation for 10 min, cells were harvested by centrifugation at
8,000  g for 10 min. The supernatant was removed and the cell pellet
resuspended in 1 ml reverse osmosis water (4°C). After shaking incubation
for 10 min (4°C), the cell suspension was centrifuged at 8,000  g for 10 min,
and osmotic shock supernatant (shockate fraction) was saved. The osmotic
shockate was concentrated by centrifugation at 100,000  g for 1 h at 4°C or
precipitation with 5% trichloroacetic acid (TCA), and the resulting pellet was
resuspended in 20 l of 5 Laemmli buffer. The remaining cell pellet was
resuspended in 400 l 5 Laemmli buffer. Samples were boiled for 5 min and
centrifuged at 400  g for 5 min, and the proteins were analyzed using
Tricine–SDS-PAGE or 12.5% SDS-PAGE as described above.
Electron microscopy. T pili in the ABIM plate supernatant were treated with
1 M MgCl2 (0.1 M final concentration), incubated overnight at 4°C, and har-
vested by centrifugation at 16,000  g for 1.5 h at 4°C. The pellet was resus-
pended in 10 mM Tris-Cl (pH 8.0) and fractionated through a 20 to 70% sucrose
density gradient at 99,000  g for 4.5 h at 4°C. Fractions (400 l) containing T
pili were pooled and centrifuged at 124,000  g for 1 h at 4°C. The pellet was
resuspended in 10 mM Tris-Cl (pH 8.0), and the material was centrifuged
through a 1.1- to 1.5-g/ml CsCl step gradient for 18 h at 5°C at 120,000  g (24).
Fractions (250 l) containing T pili were pooled and centrifuged at 124,000  g
for 1 h at 4°C. The pellet was resuspended in 10 mM Tris-Cl (pH 8.0) and further
diluted to 4 ml before centrifugation at 124,000  g for 1 h at 4°C. The pellet was
resuspended in 50 l of 50 mM HEPES, and a 5-l sample containing T pili was
placed on a 300-mesh carbon-Formvar grid (Ted Pella, Inc.) and stained with 1%
uranyl acetate (Ted Pella, Inc.). Pilus samples were examined with a JOEL 1400
electron microscope.
RESULTS
VirB2 Cys mutant phenotypes. Mutation of Cys64, the only
Cys residue in mature VirB2, to Ser results in a slight reduction
in virulence when assays are carried out at ambient (25°C)
temperature (61). However, at a lower temperature (20°C),
which was shown to be optimal for VirB/VirD4 T4SS function
(4), the Cys64Ser mutant pilin accumulated at wild-type (WT)
levels (Fig. 1A), and the mutant strains exhibited near-wild-
type substrate transfer frequencies as monitored by viru-
lence and IncQ plasmid transfer to agrobacterial recipient
cells (Fig. 1B). Further, the T pili assembled from the native
and Cys64Ser mutant pilins displayed similar fractionation
properties in sucrose gradients and appeared morphologically
indistinguishable as assessed by uranyl acetate staining and
electron microscopy (Fig. 1C and D). These near-WT pheno-
types permitted use of Cys-less VirB2 for introduction of single
Cys substitution mutations at five- to seven-residue intervals
along the length of the mature pilin.
Initial phenotypic studies showed that all 16 Cys-substituted
pilins comigrated with native VirB2 in protein gels and that
most had little or no effect on pilin function, as monitored by
substrate transfer and pilus production (Fig. 1). Two mutations
near the N terminus, Gly51Cys and Thr54Cys, exerted desta-
bilizing effects, although both mutant pilins were readily de-
tectable in membrane preparations (Fig. 1A). These mutations
as well as three other mutations located near the N-C cycliza-
tion junction, Thr58Cys, Leu117Cys, and Gly119Cys, com-
pletely blocked substrate transfer (Fig. 1B). Of these, only the
Gly51Cys and Leu117Cys mutations also completely blocked T
pilus production (Fig. 1B). Strains producing the Gly119Cys
mutant pilin accumulated high levels of T pili, and further
studies indicated that the pili were morphologically indis-
tinguishable from pili assembled from native VirB2 or the
Cys64Ser mutant (Fig. 1C and D). The Gly119Cys mutation
therefore selectively blocks substrate transfer without discern-
ible effects on pilus production.
VirB2 inner membrane topology. VirB2 possesses two
stretches of hydrophobic residues and two hydrophilic regions;
here, we will adopt a nomenclature devised for the VirB2
homolog TraAF in referring to these domains (Fig. 2A) (56).
To define the IM topology of the cyclized pilin and assay for
possible effects of VirB proteins on pilin structure, we treated
cells producing the Cys-substituted pilins with the biotinylated
maleimide probe MPB. MPB (542 Da) transits the outer mem-
brane (OM) through porins but only inefficiently crosses the
IM (9, 49, 50). MPB therefore labels periplasmic Cys residues
but not those buried in structural folds or membranes or res-
idues located in the cytoplasm. Because the early pilin process-
ing and membrane integration reactions proceed indepen-
dently of VirB proteins (47), we first developed a topology
model for the membrane-integrated pilin in a virB operon
mutant background.
As shown in Fig. 2B, Cys residues distributed throughout the
hydrophilic domain I formed by head-to-tail cyclization were
labeled upon MPB treatment of intact cells. MPB labeling was
blocked by pretreatment with the membrane-impermeative,
nonbiotinylated maleimide derivative AMS, consistent with a
periplasmic location for this hydrophilic loop (8, 9). Interest-
ingly, native Cys64 was not MPB labeled in the virB operon
mutant background, even though flanking Cys replacements at
positions 54, 58, 67, and 71 were labeled (Fig. 2B). Previous
studies have shown that Cys residues near a membrane inter-
face or in a structural fold that are inaccessible to thiol-reactive
reagents at pH 7.5 can be rendered accessible when labeling is
carried out at alkaline pH of 9 or higher (8). At pH 9.5, Cys64
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was MPB labeled (Fig. 2C), suggesting that this residue is
buried in a structural fold in the periplasm when the pilin is
produced in the absence of other VirB proteins. Cys residues
located within both hydrophobic domains II and IV or in the
intervening hydrophilic loop (Cys94) were not labeled under
neutral or alkaline reaction conditions (Fig. 2B and C). How-
ever, Cys94 was labeled upon treatment of sonicated cell ex-
tracts (Fig. 2C), indicating that this residue is located in the
cytoplasm. As expected, substitutions in the hydrophobic do-
mains were not labeled upon treatment of sonicated cell ex-
tracts (Fig. 2C).
Overall, the observed MPB labeling patterns support a to-
pology model for the membrane-integrated pilin as depicted in
Fig. 2D. This topology model is compatible with predictions
that the signal sequence cleavage and N-C cyclization reactions
occur in the periplasm (24, 25). A cytoplasmic location for the
positively charged (GRASL) central loop is also in accor-
dance with the positive-inside rule (71).
Disposition of VirB2 in VirB-producing cells and T pili.
Next, we asked whether the Cys-substituted pilins exhibited
differences in MPB labeling when synthesized in the presence
of other VirB proteins. Overall, we detected three differences
in MPB labeling patterns of Cys-substituted pilins produced in
the absence versus presence other VirB proteins (Fig. 3A).
Two residues in hydrophilic domain I, Cys51 and Cys64, dis-
played opposite labeling patterns: Cys51 was labeled only in a
strain lacking other VirB proteins, whereas Cys64 was labeled
only in the VirB-producing strain. Most intriguingly, however,
Cys94, located in the hydrophilic domain III, was labeled only
in the VirB-producing strain. Previously, using the same ex-
perimental conditions, we showed that Cys replacements in the
N-terminal cytoplasmic domain of the bitopic protein VirB10
(40) as well as cytoplasmic loops of polytopic VirB6 (41) were
not labeled upon MPB treatment of whole cells but were la-
beled upon treatment of sonicated cell extracts. Here, we fur-
ther confirmed that none of the four Cys residues of native
FIG. 1. Phenotypes of VirB2 Cys substitution mutations. (A) Effects of mutations on total cellular and membrane levels of VirB2. Total cellular
material and membrane fractions were subjected to SDS-PAGE, and immunoblots were developed with anti-VirB2 antibodies. Protein samples
were loaded on a per-cell-equivalent basis. (B) Upper panel, effects of mutations on T-DNA transfer as monitored by virulence on wounded
Kalanchoe leaves (black bars) (, avirulent; , WT virulence) and transfer of the mobilizable IncQ plasmid pML122 to A. tumefaciens
recipients (gray bars) (Tc’s/Donor, number of transconjugants per donor cell). Lower panel, effects of mutations on T pilus production, as
monitored by VirB2 abundance recovered from the shear fraction by ultracentrifugation (top) and colony immunoblots developed with anti-VirB2
antibodies (bottom). (C and D) Pilin fractionation profiles and pilus morphologies produced by virB2 mutant strains synthesizing native VirB2
(Cys64; WT) or the Cys64Ser (C64S) or Gly119Cys (G119C) mutant protein. (C) Distribution profiles of extracellular pilins in identically prepared
20 to 70% sucrose density gradients, as monitored by immunoblot development with anti-VirB2 antibodies. (D) Morphologies of pili from peak
sucrose gradient fractions, as detected by uranyl acetate staining and electron microscopy.
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VirB11, a peripheral membrane ATPase (58), was accessible to
MPB upon treatment of cells producing the VirB2 Cys94 vari-
ant (data not shown). These findings indicate that MPB label-
ing of Cys94 in a functionally WT strain is not due to cell lysis
or MPB diffusion across the IM.
We were also interested in comparing MPB labeling profiles
of pilins associated with the cell versus the T pilus. In contrast
to the profiles obtained for cell-associated pilins, only three
residues were labeled upon treatment of isolated T pili,
namely, Cys64 and Cys67 in the hydrophilic N-C loop domain
I and Cys77 within hydrophobic domain II (Fig. 3B). Cys res-
idues at positions 54 and 58 in domain I did not label, even
though these strains produced some pili (Fig. 2B); Cys51 and
Cys71 substitutions completely blocked pilus production, pre-
venting a test for surface accessibility in the T pilus. However,
another domain I substitution, Cys119, was not labeled in iso-
lated T pili, nor was Cys94 in the central hydrophilic loop (Fig.
3B). A region of the hydrophilic N-C loop including residues
64 to 71 and part of hydrophobic domain II (residues 72 to 77)
thus appears to form a surface patch in the T pilus. The
remainder of hydrophobic domain II, all of hydrophobic do-
main IV, and the small central hydrophilic domain III are
MPB inaccessible and likely buried in the T pilus.
VirB4 and VirB11 ATPases influence the disposition of
membrane pilin. We next wanted to identify the VirB pro-
teins(s) responsible for mediating the observed differences in
MPB labeling of cell-associated pilins when synthesized in
VirB-lacking versus VirB-producing cells. We reasoned that
the simplest explanation for MPB accessibility of Cys94 is that
one or more VirB/VirD4 T4SS subunits catalyze a structural
FIG. 2. MPB accessibility of Cys substitutions. (A) Predicted domain architecture of VirB2. Numbers correspond to the N and C termini of
mature pilin and a compilation of hydrophobic domain (gray cylinders) boundaries as predicted by computer hydropathy programs: TMHMM
(boundaries predicted: TM1 66 and 88, TM2 92 and 114), Mobyle (70 and 90, 93 and 113), Phobius (65 and 87, 94 and 113), SOUSI (61 and 83,
91 and 113), and HMMTOP (63 and 85, 92 and 114). Domain numbering (I to IV) follows the nomenclature devised for the VirB2 homolog, TraA,
of the F plasmid (56). (B) virB operon strains producing pilins with Cys substitutions at the residues indicated were treated with thiol-reactive
MPB without and with pretreatment with AMS. Cys-substituted pilins were isolated by immunoprecipitation and analyzed for MPB labeling.
Immunoprecipitates also were analyzed for VirB2 protein abundance by blot development with anti-VirB2 antibodies (B2). (C) MPB labeling
profiles obtained by treatment of intact and lysed cells (by sonication) at neutral and alkaline pH. (D) A topology model for membrane-integrated
VirB2 pilin. Thick black-outlined circles with gray centers, Cys substitution mutations at these positions were labeled by MPB treatment of intact
cells; thick black-outlined circles with white centers, substitutions at these positions were not labeled under any condition; gray circles with gray
outlines, substitutions labeled upon sonication (Cys94) or MPB treatment at alkaline pH (Cys64). Peri, periplasm; IM, inner membrane; Cyto,
cytoplasm. Bar, N-C cyclization junction.
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reorganization of pilin so that its cytoplasmic loop is exposed in
the periplasm. In this T4SS, the VirB4 and VirB11 ATPases
are required for assembly of the T pilus, and both VirB
ATPases plus the VirD4 ATPase (the substrate receptor) are
required for substrate translocation (16). To test a hypothesis
that one or more of the ATPases catalyze a topological reor-
ganization of pilin, we developed MPB labeling profiles for the
Cys-substituted pilins synthesized in strains lacking or produc-
ing these T4SS ATPases.
We did not detect any effects of the VirD4 substrate recep-
tor on MPB labeling patterns (J. E. Kerr, unpublished data).
Intriguingly, however, in VirB4-producing strains, we detected
MPB labeling of Cys94. As shown in Fig. 4, the Cys94-substi-
tuted pilin was labeled in a virB4 mutant complemented with
native VirB4 in trans but not in the virB4 parental strain or a
virB4 strain engineered to synthesize a Walker A NTP bind-
ing motif mutant (K439Q) (Fig. 4A). virB4 strains producing
either native VirB4 or the K439Q mutant accumulate these
proteins at comparable levels and display WT Tra Pil and
Tra Pil null phenotypes, respectively (7, 20). Also of inter-
est, the Cys94-substituted pilin was MPB labeled when copro-
duced with VirB4 in a virB operon strain but not when syn-
thesized in virB operon strains lacking VirB4 or producing
the K439Q Walker A mutant (Fig. 4B). In all VirB4-producing
strains, other Cys substitutions located in hydrophilic domain I
were labeled, arguing against the notion that VirB4 induces a
topological inversion of the pilin in the IM (Fig. 4B and data
not shown).
VirB4 was also required for labeling of Cys64 (Fig. 4A).
However, in this case, (i) both the native and Walker A mutant
forms of VirB4 mediated Cys64 labeling, and (ii) VirB4 ex-
erted its effects on Cys64 labeling only in the presence of one
or more other VirB proteins (Fig. 4A and B; see below).
Finally, VirB4 synthesis did not affect the Cys51 labeling pat-
tern (Fig. 4A and B).
We identified one VirB11-dependent change in MPB label-
ing (Fig. 5A and B). Periplasmic Cys64 was labeled in a
FIG. 3. (A) Comparison of MPB labeling patterns of Cys-substi-
tuted pilins synthesized in the absence (virB) or presence (virB2) of
other VirB proteins. Pilins (B2*) carried Cys substitutions at the res-
idues indicated at the tops of the blots. Intact cells and cell lysates were
MPB treated and analyzed as described in the text. VirB2 protein
abundance in immunoprecipitates was assessed by immunoblot analy-
sis with anti-VirB2 antibodies (B2). Schematic diagrams of MPB
labeling patterns are presented below the blots for each strain. Thin
lines, hydrophilic loops; gray cylinders, hydrophobic domains; bar,
cyclization junction; black-filled circles, MPB labeled upon treatment
of intact cells; gray-filled circles, no MPB labeling. IM, inner mem-
brane. Data are presented only for Cys replacements displaying dif-
ferences in labeling patterns between the two genetic backgrounds.
(B) MPB labeling patterns of pilins incorporated into the T pilus.
Corresponding colony immunoblots developed with anti-VirB2 anti-
bodies are shown for each mutant strain. The schematic at the right
shows MPB accessibility of Cys residues in the isolated T pilus. Black
and gray circles, accessible and inaccessible residues, respectively.
FIG. 4. Effects of VirB4 ATPase on MPB labeling patterns of pilins. (A) Cys-substituted pilins synthesized in strain JK1204 deleted of native
virB2 and virB4 (nonpolar virB2, virB4). (B) Cys-substituted pilins produced in strain PC1000 (virB operon mutant). JK1204 and PC1000 were
engineered to synthesize mutant pilins (B2*) with Cys substitutions at the residues indicated at the tops of the blots alone or with native VirB4
(B4) or a Walker A mutant (KQ) derivative. Panels showing MPB labeling patterns, VirB2* abundance in the immunoprecipitates, and schematic
representations of the labeling patterns are as described in the Fig. 3A legend. Data are presented only for Cys replacements displaying differences
in labeling patterns among the strains analyzed.
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virB11 mutant complemented with virB11 in trans but not in
the isogenic virB11 strains lacking VirB11 or producing a
VirB11 Walker A mutant (K175Q) (58). Cys64 was labeled
only in a strain producing VirB11 and other VirB proteins,
suggesting that VirB11 coordinates with at least one other
VirB protein to induce a structural change in the periplasmic
domain of VirB2 (see below).
VirB4 and VirB11 coordinate structural changes of mem-
brane-integrated pilin. In the studies described above, exper-
iments were designed to test for effects of each VirB ATPase
on the pilin structural organization. Next, we asked whether
VirB4 and VirB11 function together to catalyze structural
changes independently of other VirB proteins (Fig. 5C). As
expected from the results described above (Fig. 4B), Cys94 was
MPB labeled in a strain coproducing the mutant pilin and both
ATPases. Strikingly, however, Cys64 also was labeled, showing
that synthesis of VirB4 and VirB11 is necessary and sufficient
for labeling of this periplasmic residue. Cys51 was also labeled
in this strain (Fig. 5C), but this residue is also labeled even in
the complete absence of other VirB proteins (Fig. 3A).
Taken together, the results of our MPB labeling studies
identified an individual effect of VirB4 and a combined effect
of VirB4 and VirB11 on the structural organization of VirB2
(Fig. 6A). Synthesis of native VirB4 sufficed among the VirB
proteins for labeling of Cys94, cosynthesis of VirB4 and
VirB11 sufficed for labeling of Cys64, and Cys51 was labeled
only in the absence of one or more other VirB proteins. For-
mulated as steps in a T4SS biogenesis pathway, we propose a
working model in which (i) VirB4 catalyzes dislocation of
VirB2 from the IM (rendering Cys94 accessibility), ii) VirB11
coordinates with VirB4 (most likely prior to pilin dislocation)
to induce a structural change in the periplasmic domain of the
pilin (rendering Cys64 accessibility), and (iii) VirB4 and
VirB11 coordinate with other VirB proteins to mediate pilin
binding with a VirB partner protein(s) (rendering Cys51 inac-
cessibility) required for further channel and T pilus assembly
(Fig. 6A).
Formation of a precipitable VirB2-VirB4 complex. An as-
sumption of this model is that VirB4 interacts with VirB2 pilin.
As shown in Fig. 6B, we found that the anti-VirB2 and anti-
VirB4 antibodies each coprecipitated VirB2 and VirB4 regard-
less of the synthesis of other VirB subunits. The antibodies also
FIG. 5. Effects of VirB11 ATPase synthesis on MPB labeling patterns of pilins. (A) Cys-substituted pilins synthesized in strain PC1211
(nonpolar virB2, virB11). (B and C) Cys-substituted pilins produced in strain PC1000 (virB operon mutant). PC1211 and PC1000 were
engineered to synthesize mutant pilins (B2*) with Cys substitutions at the residues indicated at the tops of the blots alone or together with VirB11
(B11), a VirB11 Walker A mutant (KQ) derivative, or both native VirB11 and VirB4. Panels showing MPB labeling patterns, VirB2* abundance
in the immunoprecipitates, and schematic representations of the labeling patterns are as described in the Fig. 3 legend. Data are presented only
for Cys replacements displaying differences in labeling patterns among the strains analyzed.
FIG. 6. (A) Schematic summarizing effects of VirB4, VirB11, and
other VirB subunits on VirB2 MPB labeling patterns. (B) VirB protein
complexes isolated from detergent-solubilized membrane extracts by
immunoprecipitation (IP) with anti-VirB2 or anti-VirB4 antiserum.
Strains: virB4, PC1004; virB2, JK1002; virB operon, PC1000;
virB11, PC1011 (engineered to synthesize the VirB proteins indicated
in addition to those produced from the Ti plasmid). B2, VirB2; B4,
VirB4; B4KQ, VirB4K439Q; B11, VirB11. Anti-VirB2 (B2) and anti-
VirB4 (B4) antibodies were used for immunoprecipitation (IP) (left)
and development of immunoblots (Blot Dev) (right).
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coprecipitated a presumptive complex of VirB2 and the VirB4
Walker A mutant protein independently of other VirB sub-
units. Neither the anti-VirB2 nor anti-VirB4 antibodies pre-
cipitated VirB4 or VirB2 proteins nonspecifically. These find-
ings suggest that VirB4 exerts its effect on VirB2 through a
direct protein-protein contact. In contrast, the anti-VirB2 an-
tibodies did not precipitate detectable levels of VirB11, indi-
cating that VirB11 might exert its effect on VirB2 indirectly
through transient or weak-affinity interactions with VirB4.
VirB4-mediated release of VirB2 upon osmotic shock. To
complement the Cys accessibility studies described above, we
assayed for VirB4-mediated release of VirB2 upon osmotic
shock treatment of cells. VirB2 accumulated at appreciably
higher levels in material released by osmotic shock (shockate)
of WT strain A348 and a virB4 mutant complemented with
virB4 in trans than in material released from the isogenic
virB4 strains lacking VirB4 or producing the VirB4 K439Q
Walker A mutant (Fig. 7). VirB2 also accumulated at appre-
ciably higher levels in the shockate of a virB operon mutant
coproducing only VirB4 and VirB2 among the VirB proteins
than in those of isogenic strains lacking VirB4 or producing the
VirB4 K439Q Walker A mutant. VirB2 also accumulated at
low levels in the shockate fraction of cells producing only
VirB11, providing additional evidence that VirB11 alone does
not mediate release of pilin from the IM.
To evaluate whether cell lysis accompanied osmotic shock
treatment or whether VirB4 synthesis disrupted integrity of the
IM or induced release of IM vesicles, shockate fractions were
examined for the presence of cytoplasmic (VirE2) and
periplasmic (ChvE) markers and of IM (VirB10 and VirB11)
and OM (VirB7 and porins) markers. As shown in Fig. 7A and
B, a small amount of the VirE2 secretion substrate was detect-
able in shockates independently of the VirB/VirD4 T4SS, as
previously reported (12, 17); even so, levels of released VirE2
were unaffected by VirB4 synthesis. Periplasmic ChvE accu-
mulated at abundant levels in the shockates, and levels were
also unaffected by VirB4 synthesis. The IM markers, VirB10
and VirB11 (40, 58), were detectable at very low levels in the
shockate fractions and abundantly in the cell pellets separated
from the shockate fractions by centrifugation. Finally, OM
VirB7 was detected at comparable levels in shockates from all
VirB7-producing strains. We lack antibodies to A. tumefaciens
porins; however, prominent protein species characteristic of
the 30- to 40-kDa OM porins were also visualized in the
shockate fractions by SDS-PAGE and Coomassie blue staining
(data not shown). The results of these experiments suggest that
osmotic shock treatment did not induce massive cell lysis and,
furthermore, that VirB4 synthesis did not disrupt membrane
integrity or induce vesicle formation.
DISCUSSION
In this study, we developed MPB accessibility profiles for a
collection of Cys-substituted pilins with the aim of defining
intermediary steps of the VirB/VirD4 T4SS assembly pathway.
We supplied evidence for a new role for the VirB4 ATPase in
catalyzing extraction of pilin monomers from the IM, and we
also advanced an understanding of the pilin structural state
when integrated in the IM and polymerized as the extracellular
T pilus.
Our MPB accessibility studies showed that VirB4 mediates
MPB labeling of Cys94, a substitution that in the absence of
the ATPase is located in the cytoplasm (Fig. 2 and 3). VirB4
synthesis does not appear to affect cell growth or IM perme-
ability to MPB, as we were unable to detect labeling of Cys
residues in cytoplasmic proteins or domains of polytopic pro-
teins in any VirB4 producing strains. The most likely explana-
tion for Cys94 labeling, therefore, is that VirB4 catalyzes ex-
traction of the pilin into the periplasmic compartment. This
proposal was further strengthened by evidence for a precipi-
table VirB2-VirB4 complex (Fig. 6) and our finding that VirB4
mediated release of VirB2 from the IM upon osmotic shock
(Fig. 7). VirB4 was both necessary and sufficient among the
VirB subunits for Cys94 labeling and VirB2 release, suggesting
that it functions as a pilin dislocase independently of other
FIG. 7. VirB4-mediated release of VirB2 upon osmotic shock
treatment, showing the presence of proteins indicated at the right in
material released by osmotic shock (OS) or in the cell pellet (CP)
obtained from centrifugation of shocked cells. (A) Detection of VirB2,
periplasmic ChvE, and cytoplasmic VirE2. (B) Detection of outer
membrane protein VirB7 and inner membrane proteins VirB10 and
VirB11. Strains: virB2 virB4, JK1204; virB, PC1000; WT, A348
(engineered to synthesize the VirB proteins listed in addition to those
produced from the Ti plasmid). B2, VirB2; B4, VirB4; B4KQ,
VirB4K439Q; B11, VirB11; B11KQ, VirB11K175Q.
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channel constituents. A Walker A mutation also abolished
both activities, suggesting that VirB4 acts catalytically through
ATP binding/hydrolysis. Here, we characterized effects of a
K439Q Walker A mutation on the VirB2 structural organiza-
tion, as this mutation was shown previously to abolish VirB/
VirD4-mediated substrate transfer and pilus biogenesis (7, 20,
21). Similar charge-altering substitutions of conserved Walker
A or B residues of VirB4 or homologs TrbERP4 and TrwKR388
also block protein function, and such mutations correspond-
ingly abolish TrwKR388 ATPase activity in vitro (2). Other
Walker A mutations preserving the structure or charge of
the ATP binding pocket, e.g., VirB4(K439R) (74) and
TrbERP4(G495A, K501A) (57), confer partial-function phe-
notypes. In one case, this was cited as evidence that VirB4
ATPase activity is not required for pilus biogenesis (74), but a
more likely explanation is that the K439R mutant protein re-
tains ATP binding or hydrolysis at levels sufficient for residual
protein function.
VirB4 has been difficult to characterize in vitro due to prob-
lems of insolubility (57), yet the described biochemical prop-
erties of VirB4 or its homologs are reminiscent of other known
or proposed membrane dislocases. There is in silico (53) and
compelling experimental (2, 23) evidence for oligomerization
of VirB4 or VirB4-like TraBpKM101 and TrwKR388 as homo-
hexamers. These proteins also adopt other oligomeric states in
vitro, e.g., dimers, but only the hexameric forms are catalyti-
cally active (23). A. tumefaciens VirB4 also embeds into or
spans the IM (20), and membrane-associated forms of
TraBpKM101, TrwKR388, and VirB4-like TraCF were also detected
by fractionation (2, 23, 65). Finally, several VirB4-like ATPases
form stabilizing interactions with other channel components;
A. tumefaciens VirB4 interacts with VirB3 and VirB8 (55, 74),
as well as VirB10 and the VirD4 and VirB11 ATPases (3).
These physical properties—ATPase activity, homohexamer
formation, and association with membrane and membrane
proteins—are shared by the FtsH dislocase/protease as well as
the GspE ATPases implicated in functioning as pilin dislocases
during assembly of the type IV pilus systems (19, 37, 38, 63).
The GspE ATPases are related to A. tumefaciens VirB11, and
several of these family members have been shown to undergo
profound conformational changes upon ATP hydrolysis (35,
63, 64, 73). Although our data indicate that VirB4, not VirB11,
functions as a dislocation motor, we did find that both ATPases
act synergistically to induce a structural change in the pilin as
detected by labeling of periplasmic Cys64 (Fig. 5C). VirB11
might modulate VirB4 dislocase activity through ATP-medi-
ated conformational changes to regulate pilin binding or
release or induce a structural state necessary for formation
of pilin binding partner interactions in the periplasm. Al-
ternatively, assembly of a VirB4-VirB11 ternary complex
might be important for sensing and integrating spatial, tempo-
ral, or other signals controlling machine morphogenesis. Our
ongoing studies are examining these possibilities to gain a
more detailed mechanistic understanding of how VirB4 coor-
dinates with VirB11 to energize extraction of pilin subunits
from the membrane.
Besides exploiting the power of SCAM to define the topo-
logical orientation of VirB2 in the IM and identify VirB4/
VirB11-mediated dynamic changes in the pilin structural state,
our phenotypic studies of the Cys-substituted pilins generated
new insights regarding the contributions of residues/domains
to VirB2 function. Although substitutions in domains II, III,
and IV were phenotypically silent, several in domain I dis-
rupted protein function (Fig. 2). As might be expected, some
substitutions near the processing/cyclization junction were de-
stabilizing (Cys51 and Cys54) or blocked protein function with-
out discernible effects on stability (Cys117). Similar effects
were described earlier for mutations located near the cleavage
site but within the signal sequence (47). However, some sub-
stitutions near the cyclization junction (Cys54, Cys58, and
Cys119) selectively blocked substrate transfer without affecting
T pilus biogenesis. These Cys substitutions did not appear to
affect early pilin-processing reactions; we detected only the
mature pilins in protein gels, and the mutant pilins were also
resistant to carboxypeptidase, suggestive of head-to-tail cycli-
zation (J. E. Kerr, unpublished data). In studies of the related
pilins TraAF (30, 52) and TrbCRP4 (25), Tra
 Pil “uncou-
pling” mutations were also recovered in the hydrophilic do-
mains (30, 52). These findings underscore the general notion
that conjugative pilins are configured differently in the mating
channel and pilus. They also point to the importance of the
hydrophilic regions of pilins specifically for substrate transfer.
Our domain I substitutions in VirB2 were MPB labeled (Fig.
2), raising the possibility that these hydrophilic residues are
exposed in the interior of the translocation channel; if so, the
Cys54, Cys58, and Cys119 substitutions might directly impede
substrate translocation through structural effects on channel
architecture. Alternatively, the differential labeling of domain
I residues Cys51 and Cys64 in strains lacking versus producing
other VirB proteins (Fig. 3) is consistent with the notion that
the Tra Pil “uncoupling” mutations might selectively disrupt
formation of pilin contacts with another VirB subunit(s) re-
quired for assembly of the translocation channel but dispens-
able for T pilus production.
Our MPB labeling studies also supplied new information
relating to the packing geometry of VirB2 in the T pilus.
Hydrophobic domains II and IV are probably buried in pack-
ing interfaces between adjacent pilins. The central hydrophilic
loop (domain III), marked by Cys94, as well as the N-C cycli-
zation junction site of domain I, marked by Cys54, Cys58, and
Cys119, also appear to be buried in the interior of the T pilus.
If the T pilus has a central lumen analogous to that detected
for the F pilus (69, 72), these hydrophilic regions might line the
pilus lumen. Interestingly, whereas the central domain III of
TraAF is also buried in the F pilus, its C terminus is surface
displayed and can even accommodate epitope tags that are
accessible to antibody (60). We were unable to generate func-
tional forms of VirB2 bearing epitope tags near the N-C junc-
tion, preventing conclusions regarding surface display of this
region of VirB2 (J. E. Kerr, unpublished data). However, por-
tions of hydrophilic domain I, as shown by labeling of Cys64
and Cys67, and of hydrophobic domain II, as shown by labeling
of Cys77, are surface displayed (Fig. 3B). Residues 64 to 69 of
VirB2 correspond to residues 17 to 22 of TraAF, a region also
found to be exposed laterally on the pilus by bacteriophage
binding and antibody labeling of immunodominant epitopes
(30, 52, 60). The surface display of a stretch of hydrophobicity
of VirB2 (marked by Cys77 labeling) is intriguing in view of
observations that, in contrast to F pili, which dynamically ex-
tend and retract (18), T pili and related pili are sloughed or
4932 KERR AND CHRISTIE J. BACTERIOL.
broken from the cell surface. The released fibers are thought to
promote nonspecific cell-cell aggregation as a prerequisite to
mating junction formation (66). A VirB2 packing geometry
resulting in patches of surface hydrophobicity might account
for the tendency of T pili to bundle and induce cellular aggre-
gation.
Although a detailed understanding of VirB2 structural or-
ganization in the secretion channel and T pilus will require
further investigation, recent advances in knowledge of the
structure of the envelope-spanning “core” complex from the
pKM101 conjugation system have shed light on the overall
T4SS architecture. This “core” complex is composed of 14
copies each of TraN, TraO, and TraF, which are homologs of
A. tumefaciens VirB7, VirB9, and VirB10, respectively (11, 29).
The core is configured as a large, ring-shaped complex of 185
Å in length and width, whose interior chamber ranges from 8
nm at the widest point to 5 nm at the IM and 3 nm at the OM
(11, 29). The chamber is sufficient in size to accommodate the
translocation channel and, possibly, the T pilus (11, 15, 29). In
the context of our present findings, we suggest that VirB4 and
probably also VirB11 spatially position near or at the base of
the core complex where the two ATPases couple pilin extrac-
tion to translocation into the core chamber. This fits with
earlier evidence for complex formation between VirB10 and
the VirB4/VirB11/VirD4 ATPases (3) and with more recently
described interaction networks among VirB3, VirB4, VirB5,
and VirB8 that have been postulated to be important for T
pilus biogenesis (55, 74). Conceivably, these VirB proteins
assemble as a substructure within the core chamber, and the
membrane-extracted pilin monomers interact dynamically or
stably with this substructure to complete channel or pilus mor-
phogenesis.
In sum, we have presented evidence for a new function for
A. tumefaciens VirB4 as a pilin dislocase. Given that VirB4-like
subunits are signatures of all bacterial and archaeal T4SSs (1),
it is tempting to propose a universal mechanism in which
VirB4-like subunits catalyze the extraction of pilins or other
hydrophobic proteins for use in assembly of the extramembra-
nous portions of the translocation channel.
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